Drug intelligence / Profile preview

liberase

Development stage
Unknown
Lead developer
Roche
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Ex Vivo Application To Tissues/cells During Laboratory Procedures
01

Overview

Liberase is a proprietary blend of highly purified collagenases (isoforms I and II) and neutral proteases (such as thermolysin or dispase), formulated for efficient and gentle dissociation of tissues into viable single cells. The enzyme blends are optimized to maximize cell yield and viability while minimizing damage to cell surface proteins. Different formulations (e.g., TM, TL, TH) vary in their ratio of collagenases to neutral proteases for specific tissue types or dissociation requirements. The product is widely used in research applications such as cell isolation from various tissues (including tumor tissue), tissue engineering, regenerative medicine research, and stem cell isolation[1][2][4][5][6][7][8]. It is not intended for diagnostic or therapeutic use.

Brand names
LiberaseLiberase TMLiberase TLLiberase THLiberase DLLiberase DHLiberase MNP-SLiberase MTF C/T
Other names
liberase enzyme blend
02

Targets

COL4 (Collagen IV)COL1 (Collagen type I)COL2 (Type II Collagen)

Beyond the preview

Go deeper on liberase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liberase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call